Int J Pharm Pharm Sci, Vol 6, Issue 10, ??-??Original Article

IN VITRO ACTIVITY OF VARIOUS POTENCIES OF HOMEOPATHIC DRUG THUJA AGAINST MOLDS INVOLVED IN MYCOTIC KERATITIS

R. ASHA1, P. NISHA1, K. SUNEER KHAN2, A. MYTHILI2, A. SHAFEEQ HASSAN2, K. PANNEER SELVAM3, P. MANIKANDAN4,5, C. S. SHOBANA2,6*

1Department of Homeopathic Pharmacy, Government Homeopathic Medical College and Hospital, Iranimuttom, Trivandrum 695009, Kerala, 2Department of Microbiology, Dr. GR Damodaran College of Science, Coimbatore 641014, Tamilnadu, 3Department of Microbiology, MR Government Arts College, Mannargudi, Thiruvarur District, Tamilnadu, 4Department of Microbiology, Aravind Eye Hospital and Postgraduate Institute of Ophthalmology, Coimbatore 641014, Tamilnadu, 5Department of Medical Laboratory, Applied Medical Sciences College, Majmaah University, Kingdom of Saudi Arabia, 6Department of Microbiology, PSG College of Arts and Science, Coimbatore 641014, Tamilnadu.
Email: shobanasenthilkumar@gmail.com

Received: 03 Aug 2014 Revised and Accepted: 05 Sep 2014


ABSTRACT

Objective: Isolation and characterisation of clinically isolated fungi from mycotic keratitis and exploration of the in vitro efficacy of various potencies of homeopathic preparations of Thuja occidentalis on the ocular fungal isolates.

Methods: Clinical samples were collected from fungal keratitis patients attending a tertiary eye care hospital in Coimbatore, Tamilnadu state, India. The scrapings were also subjected to Gram staining and 10% KOH mount to detect the presence of fungal hyphae. The fungal isolates were subjected to lacto phenol cotton blue (LCB) mount employing cello tape flag method. Homeopathic drug Thuja occidentalis with various potencies viz., Q, 30 C, 200 C, 1 M, 10 M and 50 M were investigated for the growth inhibition of various fungal isolates by plate assay method. Further, a follow up analyses with varying dilutions of Q and 10 M homeopathic potencies of Thuja was carried out for the determination of minimum inhibitory concentration of both microdilution and minimum fungicidal concentration for the Biopolaris isolates.

Results: Out of 35 samples analysed, Fusarium spp. (n=5), Aspergillus flavus (n=6), Bipolaris spp. (n=3), Exserohilum spp. (n=3) and Curvularia spp (n=3) were identified. All the potencies of Thuja had good inhibitory activity against Bipolaris spp., followed by Curvularia spp., Exserohilum spp. and Aspergillus flavus. Statistical analysis revealed significant inhibition of all the test isolates by Thuja Q and 50 M. Significant growth inhibition was exhibited by Thuja 30, 200 C, I M for Bipolaris, Exserohilum & A. flavus isolate and Thuja 10 M for all the isolates tested except Fusaria. It was revealed that for the Biopolaris isolates BS1, BS2, BS3 Thuja 10 M and Thuja Q had MIC and MFC of 0.125/1020000& 0.0625/10 and 0.25/1020000 & 0.125/10, respectively.

Conclusion: The present investigation concludes that homeopathic drug Thuja has good inhibitory activity against the fungi causing keratitis, irrespective of the potencies. It is evident that no definite co-relation exists between various potencies of the same homeopathic drug with regard to their antimycotic properties.

Keywords: Mycotic keratitis, Fungal isolates, Homeopathy, Thuja occidentalis potencies and Growth inhibition.


INTRODUCTION

Keratitis is an 'inflammation of the eye’s cornea’ that results from infection by microorganisms like bacteria, fungi, virus etc. Of these organisms, fungi are responsible for 30% to 40% of corneal infection [1]. In India, nearly 30-35% of all culture positive infectious keratitis are caused by fungi [2]. This infection is difficult to treat and it can lead to severe visual impairment or blindness. Mycotic keratitis has been reported from many different parts of the world, particularly tropical areas, where it may account for more than 50% of all ocular mycoses, or all cases of microbial keratitis [3]. More than 105 species of fungi, spanning 56 genera have been reported to cause oculomycosis [4]. From these, fungal genera of Fusarium spp. and Aspergillus spp. are responsible for 70% of cases. The other fungi that cause keratitis are Curvularia spp., Alternaria spp., Bipolaris spp., Exserohilum spp., Candida spp., and Cladosporium spp. The etiologic agents of mycotic keratitis show a varying pattern with respect to geographic locality and climatic conditions. In North India, the majority of mycotic keratitis were due to filamentous fungi, namely Aspergillus and Fusarium species. Aspergillus species were the most common isolate in fungal keratitis reported by Srinivasan et al. [5]. However, Fusarium species were found to be the most common cause of fungal keratitis from South India (Madurai and Tamilnadu) by Barathi et al. [1, 6] and Srinivasan et al. [5]. Symptoms of fungal keratitis are blurred vision, a red and painful eye, increased sensitivity to light (photophobia), and excessive tearing or discharge. Usually associated with fungal ulcer is hypopyon which is mostly white fluffy appearance. Rarely, it may extend to the posterior segment to cause endophthalmitis in later stages, leading to the destruction of the eye. Keratitis due to filamentous fungi is believed to usually occur following trauma, the key predisposing factor, in healthy young males engaged in agricultural or other outdoor work. The traumatising agents can be of plant or animal origin (even dust particles), that either directly implant fungal conidia in the corneal stroma or abrade the epithelium, permitting invasion by exogenous fungi [7]. Fungal keratitis if not diagnosed and treated properly, can rapidly destroy the integrity of the eye, resulting in ocular damage. Antifungal agents used for treatment include polyenes, azoles and fluorinated pyrimidines. Prolonged use of these antibiotics may cause undesirable side effects. There are reports of in vitro antifungal resistant organisms due to the frequent use of azoles, polyenes and 5-fluorocytosines.

Hence it is highly imperative to employ alternative antifungal agent with minimum / no side effects. Thus, the quest for effective antifungal agents which are clinically safe, non toxic, with minimal or no adverse systemic drug reactions, opens window to complementary and alternative therapies like homeopathy, due to use of ultra-high dilutions of a single natural substance as its medicines. Homeopathy medicines have been long used for treatment of human diseases of fungal origin. Also homeopathy claims to treat in ophthalmic problems ranging from cataract to conjunctivitis and the treatments remain largely free of potential harm to patients. One of the important homeopathic drugs which is used for the treatment of fungal infection is Thuja occidentalis. Thuja is mainly used to treat eye problems such as eye inflammation, eye tumour; wart like growth in eyelid etc. This drug is obtained from Thuja occidentalis, an evergreen, native North American tree which grows to a mature height of 30 to 50 feet. Thuja contains an essential oil known as thujeine which has antimicrobial activity. It has been reported that Thuja 30 C and 200 C is very effective against Aspergillus flavus causing cutaneous aspergillosis in human and Thuja 50 M is effective against Aspergillus niger known to cause otomycosis [8]. In this context, the present study was carried out with the following objectives: isolation and characterisation of fungi from mycotic keratitis and exploration of the in vitro efficacy of various potencies of homeopathic preparation of T. occidentalis on the ocular fungal isolates.

MATERIALS AND METHODS

Collection and processing of samples

Clinical samples were collected from fungal keratitis patients attending a tertiary eye care hospital in Coimbatore, Tamilnadu state, India. The specimen viz., corneal scrapings and corneal swabs were collected from fungal keratitis patients by using a sterile Kimura’s spatula aseptically under slit lamp illumination after administering a local anesthetic [9]. The scrapped out materials were inoculated directly into solid media such as blood agar and Sabouraud’s dextrose agar (SDA). The scrapings were also subjected to Gram staining and 10% (KOH) mount to detect the presence of fungal hyphae [10].

Identification of fungal isolates

The fungal isolates obtained were point inoculated on the centre of SDA plates and incubated at room temperature for 3-4 days. The fungal isolates were subjected to lacto phenol cotton blue (LCB) mount employing cello tape flag method [11]. The preparation was examined microscopically under 10× and 45× for observing the details of spore body, spore morphology etc. [12]. Identified fungal isolates were subjected to single spore culture method as described by Leslie et al. [13]. All the isolates were maintained in 0.85% of saline solution in a screw capped storage vials and stored at room temperature for further studies.

Determination of antifungal activity of homeopathic drug Thuja

i) Plate assay

Homeopathic drug Thuja with various potencies viz., Q, 30 C, 200 C, 1 M, 10 M and 50 M were purchased from the manufacturer. Precisely, 0.5 ml of each potency of Thuja was mixed with 10 ml of sterile PDA at 45°C in 70 mm Petri dishes. PDA plates with 0.5 ml sterile water, 0.5 ml rectified spirit and 0.5 ml of 5 mg ketoconazole was used as growth control, spirit control and negative control, respectively. All the plates were aseptically inoculated with 1.5 mm diameter mycelial disc of test fungal isolates from 8 to 10 days old PDA culture plate. Plates were incubated at room temperature for five days. The radial diameter of the fungal growth was measured on third, fourth and fifth days of incubation. The percentage growth inhibition was calculated as follows:

Percent growth inhibition = $\frac{\text{dc} - \text{dt}}{\text{dc}}\ \times 100$, where dc is mean radial growth diameter of the control test isolate in growth control plate and dt is the mean radial growth diameter of the isolates in the treated plates.

ii) Broth microdilution assay

Using a sterile moistened swab, the spores were harvested from 7 days old PDA culture and then introduced into a tube containing sterile distilled water. Tween 20 (approximately 0.01 ml) was added to facilitate better spore suspension. The optical density (OD) of the spore suspension was adjusted using sterile distilled water to 0.15 – 0.18 at 530 nm which corresponded to the concentration of 0.5 x 106 to 4 x 106 CFU/ml. The suspension was then diluted with sterile water in the ratio 1:50 to get the final concentration of 0.4× 104 to 5× 104.The drugs chosen for the study were Thuja occidentalis Q and Thuja occidentalis 10M. The procedure was carried as per the CLSI [14] guidelines with slight modifications. For each homeopathic drug, 2 ml was taken as stock in a test tube (T1). A total of 9 test tubes were taken for dilution series and marked as T2-T10 , respectively. Precisely 1 ml of sterile RPMI-1640 media was added in all tubes except the stock (T1). From the stock (T1), 1 ml of drug was transferred in toT2 tube. The above was mixed well and 1 ml of the content was transferred to the T3 tube. This procedure was continued till the last T10 tube. From the last tube 1 ml of content was discarded. The final concentration of the drug varied based on the potency. For example, the drug dilution series of Thuja Q is represented in Table 1 Clean, dry, sterile U bottomed microtitre plate was taken and 100 µl of each drug dilution were added into each appropriate wells followed by 100 µl of prepared spore suspension. Two separate wells were maintained, one as growth control (100 µl media and 100 µl inoculum) and another as sterility control (100 µl media and 100 µl water). The titrated plates were incubated at 28°C for 48 h in gas-permeable plastic bags as to prevent drying and the results were read. The minimum concentration of antifungal agent that can inhibit the growth of fungal isolates was considered as the MIC of antifungal agents the clinical isolate.

Table 1: Dilutions of Thuja 10 M and Thuja Q employed for the antifungal susceptibility testing by broth microdilution assay.

Tubes RPMI 1640 (ml) Drug dilution (ml) Final concentration (Thuja 10 M) Final concentration (Thuja Q)
Tube 1 T1 0 2 1/10 20,000 1/10
Tube 2 T2 1 1 0.5/10 20,000 0.5/10
Tube 3 T3 1 1 0.25/10 20,000 0.25/10
Tube 4 T4 1 1 0.125/10 20,000 0.125/10
Tube 5 T5 1 1 0.0625/10 20,000 0.0625/10
Tube 6 T6 1 1 0.0312/10 20,000 0.0312/10
Tube 7 T7 1 1 0.0156/10 20,000 0.0156/10
Tube 8 T8 1 1 0.0078/10 20,000 0.0078/10
Tube 9 T9 1 1 0.0039/10 20,000 0.0039/10
Tube 10 T10 1 1 0.0019/10 20,000 0.0019/10

iii) Minimum Fungicidal Concentrations (MFC)

The wells which had a higher concentration than MIC were taken for the determination of MFC. A loop full of inoculum was taken from the microtitre plates and streaked on to the SDA plates. The plates were incubated at 25°C for 72 h. The concentration having no growth was considered as the MFC value of that particular drug.

RESULTS

The patients attending microbiology laboratory of tertiary eye care hospital in Coimbatore, with suspected keratitis were included in the present study. A total of 35 samples were obtained from the patients suffering from corneal ulcers between the period of October 2012 to January 2013. From these samples, a total of 15 isolates of bacteria and 20 isolates of fungi were obtained. These 20 fungal isolates were used for the further studies. The fungal isolates were subjected to analyses like colony morphology on PDA, KOH and LCB wet mount, for the identification of fungal genera. Out of 35 isolates analysed, Fusarium spp. (n=5), Aspergillus flavus (n=6), Bipolaris spp. (n=3), Exserohilum spp. (n=3) and Curvularia spp. (n=3) were identified and were designated as Fusarium FS1-FS5, Aspergillus flavus AS1- AS6, Bipolaris BS1-BS3, Exserohilum ES1-ES3 and Curvularia CS1-CS3, respectively.

Table 2: Percent growth inhibition of Thuja occidentalis potencies on ocular fungal isolates (n=20).

Fungal isolates Thuja Q Thuja 30 C Thuja 200 C Thuja 1M Thuja 10M Thuja 50M
BS1 97.71% 88.53% 69.42% 83.94% 83.94% 88.53%
BS2 97.71% 85.47% 74.77% 81.65% 88.53% 87.77%
BS3 97.81% 97.81% 97.81% 97.81% 97.81% 97.81%
ES1 69.17% 74.17% 67.50% 61.67% 82.50% 82.50%
ES2 46.41% 67.97% 75.16% 64.05% 60.78% 57.52%
ES3 45.32% 74.31% 73.65% 66.40% 57.18% 58.50%
CS1 85.99% 75.98% 82.98% 81.98% 73.97% 82.98%
CS2 75.56% 60.00% 74.44% 71.11% 62.22% 74.44%
CS3 46.08% 6.86% 10.78% 0.00% 41.18% 31.37%
FS1 27.44% 19.03% 36.91% 15.88% 19.03% 23.24%
FS2 33.86% 9.49% 17.32% 11.23% 19.93% 28.63%
FS3 37.94% 0.00% 0.00% 0.00% 97.00% 16.92%
FS4 41.49% 1.60% 0.00% 20.21% 0.00% 29.08%
FS5 82.46% 54.39% 61.40% 47.37% 61.40% 70.18%
AS1 37.20% 38.41% 34.78% 61.35% 32.37% 46.86%
AS2 32.14% 58.33% 42.86% 58.33% 47.62% 45.24%
AS3 66.91% 63.61% 71.05% 59.47% 71.05% 61.95%
AS4 59.85% 61.72% 69.19% 71.99% 69.19% 66.39%
AS5 43.94% 66.97% 54.95% 56.96% 47.95% 50.95%
AS6 53.14% 68.17% 64.63% 66.40% 58.44% 62.86%

Table 3: Distribution of the tested ocular fungal isolates (n=20) based on 75%-100% inhibition on treatment with various potencies of homeopathic drug Thuja occidentalis

Drug Curvularia spp. Exserohilum spp. Bipolaris spp. Fusarium spp. Aspergillus flavus No. of isolates inhibited Isolates%
Thuja Q CS1,CS2 BS1,BS2,BS3 FS5  - 6 30%
Thuja 50M CS1 ES1 BS1,BS2,BS3  - 5 25%
Thuja 30 CS1  - BS1,BS2,BS3 4 20%
Thuja 200 CS1 ES2 BS2, BS3 4 20%
Thuja 1M CS1  - BS1,BS2,BS3  - 4 20%
Thuja 10M  - ES1 BS1,BS2,BS3  - 4 20%

Table 4: Statistical analysis (Paired sample t test) of in vitro activity of various potencies of Thuja occidentalis against the ocular fungal isolates (n = 20)

Clinical Fungal Isolate Thuja potencies df Mean mean diff t stat Sig
Growth
control
Treated
Plates
Bipolaris spp. Q 2 4.43 0.10 -4.33 64.90 **
30C 2 4.43 0.41 -4.02 17.80 **
200C 2 4.43 0.84 -3.58 8.07 **
1M 2 4.43 0.53 -3.89 13.67 **
10M 2 4.43 0.43 -3.99 16.61 **
50M 2 4.43 0.38 -4.05 19.68 **
Exserohilum spp. Q 2 4.72 2.24 -2.48 16.83 **
30C 2 4.72 1.32 -3.40 14.67 **
200C 2 4.72 1.30 -3.42 9.46 **
1M 2 4.72 1.69 -3.03 10.69 **
10M 2 4.72 1.62 -3.10 26.39 **
50M 2 4.72 1.66 -3.06 25.96 **
Curvularia spp. Q 2 3.24 1.01 -2.23 5.96 **
30C 2 3.24 1.72 -1.52 2.25 ns
200C 2 3.24 1.46 -1.79 2.46 ns
1M 2 3.24 1.67 -1.58 1.81 ns
10M 2 3.24 1.33 -1.91 6.21 **
50M 2 3.24 1.22 -2.02 4.03 **
Fusarium spp. Q 4 3.20 1.89 -1.31 10.29 **
30C 4 3.20 2.82 -0.38 1.80 ns
200C 4 3.20 2.62 -0.58 2.10 ns
1M 4 3.20 2.75 -0.45 2.10 ns
10M 4 2.05 2.66 0.61 -2.79 ns
50M 4 3.20 2.23 -0.96 6.97 **
Aspergillus flavus Q 5 3.38 1.67 -1.70 5.99 **
30C 5 3.38 1.33 -2.04 8.48 **
200C 5 3.38 1.42 -1.96 6.31 **
1M 5 3.38 1.26 -2.12 12.25 **
10M 5 3.38 1.48 -1.89 6.23 **
50M 5 3.38 1.46 -1.92 8.28 **

Values are the means of triplicates of Radial diameter (cm) of growth control & treated plates on day 3, 4 and 5. Paired t test analysis. Note: * p<.05, ** p <.01, ns not significant; Critical t @ df(2)=2.92 one tailed p <.05; Critical t @ df (4)=2.13 one tailed p <.05; Critical t @ df(5)=2.02 one tailed p <.05

Plate assay results for the determination of antifungal activity of Thuja showed that the drug could inhibit the growth of fungal isolates. All the potencies of Thuja had good inhibitory activity against Bipolaris spp., followed by Curvularia spp., Exserohilum spp. and A. flavus. Thuja Q, particularly exhibited inhibition in the range of 75% -100% among 30% of the isolates tested. All the potencies of Thuja showed the highest inhibition percentage of 97.81 against Bipolaris isolate BS3. Thuja 30, 200 and 1M could not inhibit (0%) the Fusarium isolate FS3. Similarly, nil inhibition was observed for Thuja 200 & Thuja 10M for Fusarium isolate FS4 and Thuja 1M for Curvularia isolate CS 3. Among Exserohilum isolates, the maximum inhibition (82.5 %) was noted in ES 1 by Thuja 10 M and 50 M. Thuja Q, 200 and 50 M exhibited maximal inhibition of 85.99 %, 82.98 % and 82.98 % respectively for the Curvularia isolate CS 1. Among fusaria, maximal inhibition of 97% was exhibited by Thuja 10 M for the isolate FS3 followed by Thuja Q (82.46%) for the isolate FS5. With respect to A. flavus, the potencies of 10M could inhibit AS4 (71.99%) and AS3 (71.05%) maximally (Table 2 and 3). Various potencies of Thuja exhibited poor inhibition (<25%) on majority of the Fusarium isolates (FS1, FS2, FS3 & FS4) and also on the Curvularia isolate CS3. Statistical analysis utilising paired t test revealed significant inhibition of all the test isolates belonging to various fungal genera by Thuja Q and 50 M. Significant growth inhibition was exhibited by Thuja 30 C, 200 C, I M for Bipolaris, Exserohilum & A. flavus isolates and Thuja 10 M for all the isolates tested except fusaria. Nil inhibition with Thuja potencies was observed as follows: Thuja 10M on FS4, Thuja 30 on FS 3, Thuja 200 on FS3 and FS4 and Thuja IM on FS3 and CS3 (Table 4).

Thuja 10M showed an MIC of 0.125/1020,000 and MFC of 0.25/1020,000 for all Bipolaris isolates i.e., BS1, BS2 and BS3. Thuja Q showed an MIC of 0.0625/10 and MFC of 0.125/10 for all Bipolaris isolates (Table 5).

Table 5: MIC and MFC of Thuja 10 M and Thuja Q for Bipolaris isolates

Drug MIC MFC
Thuja 10 M 0.125/10 20,000

(4th dilution)

0.25/10

(3rd dilution)

Thuja Q 0.0625/10

(5th dilution)

0.125/10

(4th dilution)


DISCUSSION

The incidence of fungal keratitis, risk factors, and the type of agent causing may vary among different geographic regions [5, 15 & 16]. Worldwide, the reported incidence of fungal keratitis is 17% to 36% [16 - 18], whereas in India, it is 44% to 47% [5, 20-22]. The outcome of mycotic keratitis depends ultimately on the interplay of the agent (virulence, resistance to drugs, and toxicity) and host factors (predisposing factors, inflammatory response, and hypersensitivity reactions) in addition to timely diagnosis and appropriate medical treatment. In the present investigation, the common aetiological agent for corneal ulcer was identified as fungi rather than bacteria. The similar results were obtained by Bharathi et al. [1] in south India. Leck et al. [3] also reported similar results from the south, north and east India. But other studies from Thailand and Malaysia reported that the most frequent causative agent of microbiological keratitis was bacteria [23&24]. This revealed that in India fungal keratitis is more prevalent than bacterial keratitis. Mycotic keratitis is expected to be more common in tropical and subtropical locations than in the temperate regions. A hot, humid climate and an agriculture-based occupation of a large population make fungal keratitis more frequently in tropical countries. Gopinathan et al. [25] made the similar observation. In the present study a total of 20 fungal isolates viz., Fusarium spp (n=5), Aspergillus flavus (n=6), Bipolaris spp. (n=3), Exserohilum spp. (n=3), and Curvularia spp (n=3) were identified. The isolates were confirmed by microscopic and macroscopic observations. Srinivasan et al. [5] revealed that out of 155 fungal isolates cultured from 154 corneal ulcers 47.1% were Fusarium spp. 16.1% were Aspergillus spp. and the remaining organisms were a diverse mixture of unusual fungal pathogens including a large number of unidentified dematiacious fungal species (13.5%) and hyaline fungal species (9.6%). The pattern of fungal organisms, dominated by Fusarium spp. is similar to the spectrum of microbial keratitis reported from south Florida by Liesegang and Forster [4] and from Ghana by Hagan et al. [26]. By contrast, in most of the world Aspergillus spp. or Candida spp. are the predominant fungal pathogens responsible for mycotic keratitis (Jones 1975) [15]. In the temperate climate of Nepal, Upadhyay et al. [18] found that Aspergillus spp. accounted for 47% of all fungal pathogens followed by Candida spp. (13.2%) and Fusarium spp. (11.7%).

Owing to the undesirable side effects of the conventional drug of choice used for the treatment of mycotic keratitis and also, the emergence of antifungal resistant strains, the present study was carried out with an idea of analysing the potential use of homeopathic drugs in the control of molds involved in mycotic keratitis. Clausen et al. [27] has reported that, pathogenetic, prophylactic and therapeutic study designs seem to be equally suited for homeopathy basic research using high dilutions. Homeopathy proves to be the one of the best alternative treatment being economical, minimal to no side-effects claimed so far, and no known contraindications or drug interactions reported so far when used along with conventional medications. In the present study, all the potencies of Thuja had good inhibitory activity against Bipolaris spp., followed by Curvularia spp., Exserohilum spp. and A. flavus. The antifungal effect of homeopathy drugs has been reported by many workers. In vitro testing of antifungal effectiveness of Sulphur iodatum 1M and Petroleum 30 against the cellulolytic fungi Aspergillus niger was first reported by Garg [28]. Dua and Atri et al. [29] has reported fungitoxic effect of the drug Lycopodium against Alternaria solani.

The homoeopathic drugs Thuja and Natrum muriaticum were found to be effective on Fusarium spp. as reported by Hussain et al. [30]. Khanna and Chandra [31] investigated the control of tomato fruit rot caused by Fusarium roseus with homoeopathic drugs Kali iodatum (149CH) and Thuja occidentalis (87CH), in pre and post-harvest conditions and obtained significant results. Gupta et al. [32] has reported that the methanolic extract of Thuja has good activity against clinically isolated fungi. Jahan et al. [33] described the antifungal activity of T. occidentalis extracts against Saccaromyces cereviciae, A. parasiticus, Trichophyton rubrum, Macrophomina, F. solani and Candida albicans. Gupta et al. [34] has stated that Thuja 30, 200 and 10M are very effective against pathogenic isolate Curvularia lunata, however other dilutions are not much effective. Thuja Q, 30, 200 are found highly potent against A. flavus and 50M against A. niger as detailed by Srivastava [35]. The pre-treated and the post-treated data of the mean of the radial growth (cm) of ocular fungal isolates of various genera tested in the plate assay method were subjected to statistical analysis employing paired- t- tests. Most of the potencies used in the plate assay method, showed statistically significant inhibition. As varying potencies of the drug Thuja showed good inhibitory activity against Bipolaris spp. MIC and MFC analyses were carried out with the selected drugs viz., Thuja 10 M and Thuja Q against the Bipolaris isolates BS1, BS2 and BS3. Thuja 10M showed an MIC of 0.125/1020,000 and an MFC of 0.25/10 20,000whereas Thuja Q showed an MIC of 0.0625/10and an MFC of 0.125/10 for all Bipolaris isolates. Such MIC/MFC reports of in vitro activity of highly diluted-dynamized homeopathic solutions are rare.

CONCLUSION

The mode of action of the homeopathic drug Thuja is not evaluated in this study. The detailed analysis of the variation in the efficacy of different potencies of same homeopathic medicine in antifungal susceptibility testing is a subject of further study. It is highly imperative to state that the importance of in vitro studies lies in the fact that it possible to obtain preliminary evidence on the effect of high dilutions under controlled laboratory conditions, thereby testing on the main principles of homeopathy viz., similarity in the mode of action at the cellular level and the effect of drug dilution on the drug activity, here with special emphasis on antifungal susceptibility testing. Furthermore, the in vitro studies can also be utilised for finding the exact molecular targets of homeopathic agents. The present investigation concludes that homeopathic drugs have significant inhibitory activity against the fungi causing keratitis, irrespective of the potencies.

A good inhibition (75% - 100%) of Thuja (Q, 30, 1 M, 10 M & 50 M) was found among all the three isolates of Bipolaris subjected for analyses. Further, out of 5 different fungal genera tested, Thuja potencies viz., Q, 200 & 50 M were effective against 3 fungal genera. The follow up antifungal susceptibility analyses by broth microdilution utilising Thuja 10 M and Thuja Q revealed that both the potencies had inhibitory and fungicidal activity against Bipolaris isolates. It is evident that no definite co-relation exists between various potencies of the same homeopathic drug with regard to their antimycotic properties.

REFERENCES

  1. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan P. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol 2003;51:315-21.
  2. Nayak N. Fungal infections of the eye-laboratory diagnosis and treatment. Nepal Med Coll J 2008;10(1):48-63.
  3. Leck AK, Thomas PA, Hagan M, Kaliamurthy J, Ackuaku E, John M. Etiology of suppurative corneal ulcers in Ghana and South India, and epidemiology of fungal keratitis. Br J Ophthalmol 2002;86:1211–5.
  4. Wilson LA, Aejelloo L. Agents of oculomycosis: Fungal infections of the eye. In: Collier L, Balows A, Sussman A, editors. Topely and Wilson’s Microbiology and Microbial Infections, 9th ed, Arnold: London; 1998. p. 525-67.
  5. Srinivasan M, Gonzales CA, George C, Cevallos V, Mascarenhas JM, Asokan B, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, South India. Br J Ophthalmol 1997;81:965–71.
  6. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Aetiological diagnosis of microbial keratitis in South India-A study of 1618 cases. Indian J Med Microbiol 2002;20:19-24.
  7. Tilak R, Singh A, Maurya OPS, Chandra A, Tilak V, Gulati AK. Mycotic keratitis in India: a five-year retrospective study. J Infect Dev Ctries 2010;4(3):171-4.
  8. Gupta G. In vitro antimycotic potential of Thuja occidentalis against Curvulara lunata causing Phaeoyphomycosis in Human. Natl J Homoeopathy 2002;4(3):5-12.
  9. Jacob P, Gopinathan U, Sharma S, Rao GN. Calcium alginate swab versus Bard Parker blade in the diagnosis of microbial keratiits. Cornea 1995;14(4):360-4.
  10. Laila A, Salam MA, Hasan B, Begum N, Ahmed I. Etiological agents of suppurative corneal ulcer: Study of 56 cases. Bangladesh J Med Microbiol 2009;3 (1):33-6.
  11. Harris JL. Safe, low-distortion type touch method for fungal slide mounts. J Clin Microbiol 2000;38(12):4683-4.
  12. Larone DH. Medically Important Fungi-A Guide to Identification, 3rd ed. ASM Press: Washington DC; 1995.
  13. Leslie JF, Summerell BA, Bullock S. The Fusarium laboratory manual. Blackwell Publishers: Ames, Iowa, USA; 2006.
  14. CLSI Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; proposed guideline. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne; 2008.
  15. Jones BR. Principles in the management of oculomycosis. Edward jackson memorial lecture. Am J Ophthalmol 1975;79:719–51.
  16. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in south Florida. Am J Ophthalmol 1995;90:38–47.
  17. Rosa RH, Jr Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south florida. Ophthalmol 1994;101:1005–13.
  18. Upadhyay MP, Karmacharya PCD, Koirala S, Tuladhar NK, Bryan le, et al. Epidemiologic characteristics, predisposing factors and etiological diagnosis of corneal ulceration in Nepal. Am J Ophthalmol 1991;111:92-9.
  19. Katz NN, Wadud SA, Ayazuddin M. Corneal ulcer disease in Bangladesh. Ann Ophthalmol 1983;15:834–6.
  20. Dunlop AA, Wright ED, Howlader SA, Nazrul I, Husain R, McClellan K, et al. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. Aust N Z J Ophthalmol 1994;22:105-10.
  21. Polack FM, Kaufman HE, Newmark E. Keratomycosis medical and surgical treatment. Arch Ophthalmol 1994;85:410–6.
  22. Thomas PA. Mycotic keratitis: an underestimated mycosis. J Med Vet Mycol 1994;32:235–54.
  23. Sirukul T, Prabriputaloong T, Sathivat A, Chuck RS, Vongthongsri A. Predisposing factors and etiologic diagnosis of ulcerative keratitis. Cornea 2008;27(3):283-7.
  24. Norina TJ, Raihan S, Bakiah S, Ezanee M, Liza-Sharmini AT, Wan Hazzabah WH. Microbial keratitis: aetiological diagonosis and clinical features in patients admitted to hospital University Sains Malaysia. Singapore Med J 2008;49(1): 67-71.
  25. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and Laboratory results of fungal keratitis: a 10-year review at a referral eye care centre in South India. Cornea 1994;21:555-9.
  26. Hagan M, Wright E, Newman M, Dolin P, Johnson G. Causes of suppurative keratitis in Ghana. Br J Ophthalmol 1995;79:1024–8.
  27. Clausen J, van Wijk R, Henning A. Review of the use of high dilutions in basic research on homeopathy. Homeopathy 2011;100(4):288-92.
  28. Garg KL. Use of homoeopathic drugs as antifungal agent for the protection of books and paper materials. In: Aranyanak C and Singhasiri C, editors. Proceedings of the 3rd International conference on Biodeterioration of Cultural Property held at Bangkok, Thailand. Conservation Science Division, The Fine Arts Department, Bangkok, Thailand; 1995. p. 103-15.
  29. Dua VK, Atri DC. Control of tomato fruit rot caused by Alternaria Solani with Homeopathy drugs. J Bot Soc 2004;39:88-93.
  30. Hussain SZ, Anandam RJ, Rao AS. Effect of different fungicides and homeopathic drugs on seedborne fungi of sunflower (Helianthus annuus L.). Indian J Plant Prot 2000;28(2):148-51.
  31. Khanna KK, Chandra S. Effect of homeopathic drugs on respiration of germinating fungal spores. Indian Phytopathol 1992;45:348-53.
  32. Gupta S, Kiran K, Dutta A. Biocontrol of clinical fungal isolates associated with fungal keratitis using medicinal plant extract. Int J Pharm Pharm Sci 2012;4(4):544-7.
  33. Jahan N, Ahmad M, Mehjabeen M, Zia-ul-haq S, Alam L, Quereshi M. Antimicrobial screening of some medicinal plants of Pakistan. Pak J Bot 2010;42(6):4281-4.
  34. Gupta G, Srivastava AK, In vitro activity of Thuja occidentalis Linn. against human pathogenic aspergilla. Homoeopathic Heritage 2002;27(1):5-12.
  35. Srivastava AK, Lal B. Studies on biofungicidal properties of leaf extract of some plants: Indian Phyto; 1996;50(3):408-11.